
Pharmacovigilance Market Size, Share, Trends, Industry Analysis Report: By Service (In–house and Contract Outsourcing), Product Life Cycle, Type, Process Flow, Therapeutic Area, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and
Description
Pharmacovigilance Market Size, Share, Trends, Industry Analysis Report: By Service (In–house and Contract Outsourcing), Product Life Cycle, Type, Process Flow, Therapeutic Area, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2024 - 2032
The global pharmacovigilance market size is expected to reach USD 13.60 billion by 2032, according to a new study by Polaris Market Research. The report “Pharmacovigilance Market Size, Share, Trends, Industry Analysis Report: By Service (In–house and Contract Outsourcing), Product Life Cycle, Type, Process Flow, Therapeutic Area, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2024 - 2032)” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global pharmacovigilance market is experiencing growth due to increasing rates of adverse drug reactions (ADRs) and the rising adoption of pharmacovigilance software by outsourcing firms. Additionally, government regulatory bodies such as the EMEA and U.S. FDA have strengthened regulations for post- and pre-commercialization drug safety, placing greater emphasis on biotechnology and pharmacovigilance companies to develop safe drugs and monitor their post-sales outcomes. For instance, in November 2021, Deloitte and Sanofi partnered to develop ConvergeHEALTH Safety, an advanced software service platform powered by artificial intelligence (AI) for the intake of adverse event cases. This collaboration aims to revolutionize pharmacovigilance through innovative technology. Thus, the use of Artificial Intelligence in pharmacovigilance is propelling the growth of the pharmacovigilance market.
Spontaneous reporting is crucial in pharmacovigilance as it facilitates early detection of adverse events associated with drugs and medical products. This is essential for early interventions to safeguard patient safety. Regulatory requirements necessitate Pharmacovigilance firms to establish strong pharmacovigilance systems, including efficient spontaneous reporting mechanisms. Compliance demonstrates their dedication to public health and helps to boost their standing in the market.
Pharmacovigilance Market Report Highlights
- The pharmacovigilance companies segment is anticipated to experience substantial growth with a significant CAGR in the global market due to the increase in drug innovation by pharmacovigilance companies.
- The oncology segment accounted for the largest revenue share of the market in 2023 due to the rising side effects of cancer therapy being one of the most important issues faced by cancer patients during their illness.
- In 2023, North America dominated the global pharmacovigilance market due to the presence of major pharmacovigilance companies in the region.
- The pharmacovigilance market in Japan is projected for substantial growth because of the increased prevalence of chronic diseases in the region.
- The global key market players are Laboratory Corporation of America Holdings; Cognizant; Thermo Fisher Scientific Inc; ICON plc.; Accenture; IQVIA; Aris Global; IBM Corporation; United BioSource LLC; PAREXEL International Corporation; TAKE Solutions; and Pharmacovigilance Development Group, Inc.
By Service Outlook
- In¬-house
- Contract Sourcing
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Case Data Management
- Case Data Analysis
- Medical Reviewing and Reporting
- Signal Detection
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Mitigation System
By Therapeutic Area Outlook
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- North America
- Canada
- Europe
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
117 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Pharmacovigilance Market Insights
- 4.1. Pharmacovigilance Market – Application Snapshot
- 4.2. Pharmacovigilance Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing drug consumption and adverse drug reactions is Driving the Market Growth
- 4.2.2. Increased research and development activities and new drug approvals
- 4.3. Restraints and Challenges
- 4.3.1.1. Underreporting of Adverse Events
- 4.4. Porter’s Five Forces Analysis
- 4.4.1. Bargaining Power of Suppliers (Moderate)
- 4.4.2. Threats of New Entrants: (Low)
- 4.4.3. Bargaining Power of Buyers (Moderate)
- 4.4.4. Threat of Substitute (Moderate)
- 4.4.5. Rivalry among existing firms (High)
- 4.5. PESTEL Analysis
- 4.6. Pharmacovigilance Market Application Trends
- 4.7. Value Chain Analysis
- 4.8. COVID-19 Impact Analysis
- 5. Pharmacovigilance Market, by Service
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 5.3. In¬-house
- 5.3.1. Pharmacovigilance Market, by Platform, In¬-house, 2019-2032 (USD Billion)
- 5.4. Contract Sourcing
- 5.4.1. Pharmacovigilance Market, by Software, Contract Sourcing, 2019-2032 (USD Billion)
- 5.5. Pharmacovigilance Market, by Product Life Cycle
- 5.6. Key Findings
- 5.7. Introduction
- 5.7.1. Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 5.8. Pre-clinical
- 5.8.1. Pharmacovigilance Market, by Pre-clinical, by Region, 2019-2032 (USD Billion)
- 5.9. Phase I
- 5.9.1. Pharmacovigilance Market, by Phase I, by Region, 2019-2032 (USD Billion)
- 5.10. Phase II
- 5.10.1. Pharmacovigilance Market, by Phase II, by Region, 2019-2032 (USD Billion)
- 5.11. Phase III
- 5.11.1. Pharmacovigilance Market, by Phase III, by Region, 2019-2032 (USD Billion)
- 5.12. Phase IV
- 5.12.1. Pharmacovigilance Market, by Phase IV, by Region, 2019-2032 (USD Billion)
- 6. Pharmacovigilance Market, by Product Life Cycle
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 6.3. Spontaneous Reporting
- 6.3.1. Pharmacovigilance Market, by Spontaneous Reporting, by Region, 2019-2032 (USD Billion)
- 6.4. Intensified ADR Reporting
- 6.4.1. Pharmacovigilance Market, by Intensified ADR Reporting, by Region, 2019-2032 (USD Billion)
- 6.5. Targeted Spontaneous Reporting
- 6.5.1. Pharmacovigilance Market, by Targeted Spontaneous Reporting, by Region, 2019-2032 (USD Billion)
- 6.6. Cohort Event Monitoring
- 6.6.1. Pharmacovigilance Market, by Cohort Event Monitoring, by Region, 2019-2032 (USD Billion)
- 6.7. EHR Mining
- 6.7.1. Pharmacovigilance Market, by EHR Mining, by Region, 2019-2032 (USD Billion)
- 7. Pharmacovigilance Market, by Process Flow
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 7.3. Case Data Management
- 7.3.1. Pharmacovigilance Market, by Case Data Management, by Region, 2019-2032 (USD Billion)
- 7.3.2. Case Logging
- 7.3.2.1. Pharmacovigilance Market, by Case Logging, by Region, 2019-2032 (USD Billion)
- 7.3.3. Case Data Analysis
- 7.3.3.1. Pharmacovigilance Market, by Case Data Analysis, by Region, 2019-2032 (USD Billion)
- 7.3.4. Medical Reviewing and Reporting
- 7.3.4.1. Pharmacovigilance Market, by Medical Reviewing and Reporting, by Region, 2019-2032 (USD Billion)
- 7.4. Signal Detection
- 7.4.1. Pharmacovigilance Market, by Signal Detection, by Region, 2019-2032 (USD Billion)
- 7.4.2. Adverse Event Logging
- 7.4.2.1. Pharmacovigilance Market, by Adverse Event Logging, by Region, 2019-2032 (USD Billion)
- 7.4.3. Adverse Event Analysis
- 7.4.3.1. Pharmacovigilance Market, by Adverse Event Analysis, by Region, 2019-2032 (USD Billion)
- 7.4.4. Adverse Event Review & Reporting
- 7.4.4.1. Pharmacovigilance Market, by Adverse Event Review & Reporting, by Region, 2019-2032 (USD Billion)
- 7.5. Risk Management System
- 7.5.1. Pharmacovigilance Market, by Risk Management System, by Region, 2019-2032 (USD Billion)
- 7.5.2. Risk Evaluation System
- 7.5.2.1. Pharmacovigilance Market, by Risk Evaluation System, by Region, 2019-2032 (USD Billion)
- 7.5.3. Risk Mitigation System
- 7.5.3.1. Pharmacovigilance Market, by Risk Evaluation System, by Region, 2019-2032 (USD Billion)
- 8. Pharmacovigilance Market, by Therapeutic Area
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 8.3. Oncology
- 8.3.1. Pharmacovigilance Market, by Oncology, by Region, 2019-2032 (USD Billion)
- 8.4. Neurology
- 8.4.1. Pharmacovigilance Market, by Neurology, by Region, 2019-2032 (USD Billion)
- 8.5. Cardiology
- 8.5.1. Pharmacovigilance Market, by Cardiology, by Region, 2019-2032 (USD Billion)
- 8.6. Others
- 8.6.1. Pharmacovigilance Market, by Others, by Region, 2019-2032 (USD Billion)
- 9. Pharmacovigilance Market, by End Use
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 9.3. Pharmaceuticals
- 9.3.1. Pharmacovigilance Market, by Pharmaceuticals, by Region, 2019-2032 (USD Billion)
- 9.4. Biotechnology Companies
- 9.4.1. Pharmacovigilance Market, by Biotechnology Companies, by Region, 2019-2032 (USD Billion)
- 9.5. Medical Device Manufacturers
- 9.5.1. Pharmacovigilance Market, by Medical Device Manufacturers, by Region, 2019-2032 (USD Billion)
- 9.6. Others
- 9.6.1. Pharmacovigilance Market, by Others, by Region, 2019-2032 (USD Billion)
- 10. Pharmacovigilance Market, by Geography
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. Pharmacovigilance Market Assessment, By Geography, 2019-2032 (USD Billion)
- 10.3. Pharmacovigilance Market – North America
- 10.3.1. North America: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.3.2. North America: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.3.3. North America: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.3.4. North America: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.3.5. North America: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.3.6. North America: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.3.7. Pharmacovigilance Market – U.S.
- 10.3.7.1. U.S.: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.3.7.2. U.S.: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.3.7.3. U.S.: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.3.7.4. U.S.: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.3.7.5. U.S.: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.3.7.6. U.S.: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.3.8. Pharmacovigilance Market – Canada
- 10.3.8.1. Canada: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.3.8.2. Canada: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.3.8.3. Canada: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.3.8.4. Canada: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.3.8.5. Canada: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.3.8.6. Canada: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.4. Pharmacovigilance Market – Europe
- 10.4.1. Europe: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.4.2. Europe: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.4.3. Europe: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.4.4. Europe: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.4.5. Europe: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.4.6. Europe: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.4.7. Pharmacovigilance Market – UK
- 10.4.7.1. UK: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.4.7.2. UK: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.4.7.3. UK: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.4.7.4. UK: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.4.7.5. UK: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.4.7.6. UK: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.4.8. Pharmacovigilance Market – France
- 10.4.8.1. France: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.4.8.2. France: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.4.8.3. France: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.4.8.4. France: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.4.8.5. France: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.4.8.6. France: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.4.9. Pharmacovigilance Market – Germany
- 10.4.9.1. Germany: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.4.9.2. Germany: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.4.9.3. Germany: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.4.9.4. Germany: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.4.9.5. Germany: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.4.9.6. Germany: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.4.10. Pharmacovigilance Market – Italy
- 10.4.10.1. Italy: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.4.10.2. Italy: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.4.10.3. Italy: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.4.10.4. Italy: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.4.10.5. Italy: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.4.10.6. Italy: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.4.11. Pharmacovigilance Market – Spain
- 10.4.11.1. Spain: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.4.11.2. Spain: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.4.11.3. Spain: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.4.11.4. Spain: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.4.11.5. Spain: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.4.11.6. Spain: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.4.12. Pharmacovigilance Market – Netherlands
- 10.4.12.1. Netherlands: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.4.12.2. Netherlands: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.4.12.3. Netherlands: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.4.12.4. Netherlands: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.4.12.5. Netherlands: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.4.12.6. Netherlands: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.4.13. Pharmacovigilance Market – Russia
- 10.4.13.1. Russia: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.4.13.2. Russia: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.4.13.3. Russia: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.4.13.4. Russia: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.4.13.5. Russia: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.4.13.6. Russia: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.4.14. Pharmacovigilance Market – Rest of Europe
- 10.4.14.1. Rest of Europe: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.4.14.2. Rest of Europe: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.4.14.3. Rest of Europe: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.4.14.4. Rest of Europe: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.4.14.5. Rest of Europe: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.4.14.6. Rest of Europe: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.5. Pharmacovigilance Market – Asia Pacific
- 10.5.1. Asia Pacific: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.5.2. Asia Pacific: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.5.3. Asia Pacific: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.5.4. Asia Pacific: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.5.5. Asia Pacific: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.5.6. Asia Pacific: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.5.7. Pharmacovigilance Market – China
- 10.5.7.1. China: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.5.7.2. China: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.5.7.3. China: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.5.7.4. China: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.5.7.5. China: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.5.7.6. China: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.5.8. Pharmacovigilance Market – India
- 10.5.8.1. India: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.5.8.2. India: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.5.8.3. India: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.5.8.4. India: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.5.8.5. India: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.5.8.6. India: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.5.9. Pharmacovigilance Market – Malaysia
- 10.5.9.1. Malaysia: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.5.9.2. Malaysia: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.5.9.3. Malaysia: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.5.9.4. Malaysia: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.5.9.5. Malaysia: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.5.9.6. Malaysia: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.5.10. Pharmacovigilance Market – Japan
- 10.5.10.1. Japan: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.5.10.2. Japan: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.5.10.3. Japan: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.5.10.4. Japan: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.5.10.5. Japan: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.5.10.6. Japan: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.5.11. Pharmacovigilance Market – Indonesia
- 10.5.11.1. Indonesia: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.5.11.2. Indonesia: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.5.11.3. Indonesia: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.5.11.4. Indonesia: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.5.11.5. Indonesia: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.5.11.6. Indonesia: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.5.12. Pharmacovigilance Market – South Korea
- 10.5.12.1. South Korea: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.5.12.2. South Korea: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.5.12.3. South Korea: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.5.12.4. South Korea: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.5.12.5. South Korea: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.5.12.6. South Korea: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.5.13. Pharmacovigilance Market – Australia
- 10.5.13.1. Australia: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.5.13.2. Australia: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.5.13.3. Australia: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.5.13.4. Australia: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.5.13.5. Australia: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.5.13.6. Australia: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.5.14. Pharmacovigilance Market – Rest of Asia Pacific
- 10.5.14.1. Rest of Asia Pacific: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.5.14.2. Rest of Asia Pacific: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.5.14.3. Rest of Asia Pacific: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.5.14.4. Rest of Asia Pacific: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.5.14.5. Rest of Asia Pacific: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.5.14.6. Rest of Asia Pacific: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.6. Pharmacovigilance Market – Middle East & Africa
- 10.6.1. Middle East & Africa: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.6.2. Middle East & Africa: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.6.3. Middle East & Africa: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.6.4. Middle East & Africa: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.6.5. Middle East & Africa: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.6.6. Middle East & Africa: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.6.7. Pharmacovigilance Market – Saudi Arabia
- 10.6.7.1. Saudi Arabia: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.6.7.2. Saudi Arabia: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.6.7.3. Saudi Arabia: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.6.7.4. Saudi Arabia: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.6.7.5. Saudi Arabia: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.6.7.6. Saudi Arabia: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.6.8. Pharmacovigilance Market – UAE
- 10.6.8.1. UAE: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.6.8.2. UAE: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.6.8.3. UAE: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.6.8.4. UAE: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.6.8.5. UAE: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.6.8.6. UAE: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.6.9. Pharmacovigilance Market – Israel
- 10.6.9.1. Israel: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.6.9.2. Israel: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.6.9.3. Israel: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.6.9.4. Israel: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.6.9.5. Israel: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.6.9.6. Israel: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.6.10. Pharmacovigilance Market – South Africa
- 10.6.10.1. South Africa: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.6.10.2. South Africa: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.6.10.3. South Africa: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.6.10.4. South Africa: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.6.10.5. South Africa: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.6.10.6. South Africa: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.6.11. Pharmacovigilance Market – Rest of Middle East & Africa
- 10.6.11.1. Rest of Middle East & Africa: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.6.11.2. Rest of Middle East & Africa: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.6.11.3. Rest of Middle East & Africa: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.6.11.4. Rest of Middle East & Africa: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.6.11.5. Rest of Middle East & Africa: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.6.11.6. Rest of Middle East & Africa: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.7. Pharmacovigilance Market – Latin America
- 10.7.1. Latin America: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.7.2. Latin America: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.7.3. Latin America: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.7.4. Latin America: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.7.5. Latin America: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.7.6. Latin America: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.7.7. Pharmacovigilance Market – Mexico
- 10.7.7.1. Mexico: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.7.7.2. Mexico: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.7.7.3. Mexico: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.7.7.4. Mexico: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.7.7.5. Mexico: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.7.7.6. Mexico: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.7.8. Pharmacovigilance Market – Brazil
- 10.7.8.1. Brazil: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.7.8.2. Brazil: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.7.8.3. Brazil: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.7.8.4. Brazil: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.7.8.5. Brazil: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.7.8.6. Brazil: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.7.9. Pharmacovigilance Market – Argentina
- 10.7.9.1. Argentina: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.7.9.2. Argentina: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.7.9.3. Argentina: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.7.9.4. Argentina: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.7.9.5. Argentina: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.7.9.6. Argentina: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 10.7.10. Pharmacovigilance Market – Rest of Latin America
- 10.7.10.1. Rest of Latin America: Pharmacovigilance Market, by Service, 2019-2032 (USD Billion)
- 10.7.10.2. Rest of Latin America: Pharmacovigilance Market, by Product Life Cycle, 2019-2032 (USD Billion)
- 10.7.10.3. Rest of Latin America: Pharmacovigilance Market, by Type, 2019-2032 (USD Billion)
- 10.7.10.4. Rest of Latin America: Pharmacovigilance Market, by Process Flow, 2019-2032 (USD Billion)
- 10.7.10.5. Rest of Latin America: Pharmacovigilance Market, by Therapeutic Area, 2019-2032 (USD Billion)
- 10.7.10.6. Rest of Latin America: Pharmacovigilance Market, by End Use, 2019-2032 (USD Billion)
- 11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
- 12. Company Profiles
- 12.1. Laboratory Corporation of America Holdings
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Cognizant
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Thermo Fisher Scientific Inc
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. ICON plc
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. Accenture
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. IQVIA
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. Aris Global
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. IBM Corporation
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. United BioSource LLC
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. PAREXEL International Corporation
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. TAKE Services
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
- 12.12. Pharmaceutical Development Group Inc
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.